Drug · DIN 02078635
RATIO-ACYCLOVIR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 18, 2018; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02078635
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Acyclovir J05AB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACYCLOVIR | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 8, 2013: NOC 14631New Drug Submission (NDS) · Administrative merger/buyout
- October 24, 2002: NOC 196New Drug Submission (NDS) · Manufacturer and product name change
- March 10, 1994: NOC 5330New Drug Submission (NDS)
Other DINs named RATIO-ACYCLOVIR
- DIN 02078627 · Cancelled Post Market
- DIN 02078651 · Cancelled Post Market